awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30995889-CC2A75E8-3EAA-42D5-A731-9637FEA2ABDB
Q30995889-CC2A75E8-3EAA-42D5-A731-9637FEA2ABDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30995889-CC2A75E8-3EAA-42D5-A731-9637FEA2ABDB
The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?
P2860
Q30995889-CC2A75E8-3EAA-42D5-A731-9637FEA2ABDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30995889-CC2A75E8-3EAA-42D5-A731-9637FEA2ABDB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ee3cef18176060ca226ec59e08b530535c869d6
P2860
Tailoring anti-TNF therapy in IBD: drug levels and disease activity.